Resumo

MESA PEREZ, Eduardo de Jesús; PEREGRINO CALLIS, Georgia; ROSELL VALDENEBRO, Leisy  e  FONG SORRIBE, Roberto. Cost-benefit of the treatment with Heberprot-P^® in patients with diabetic foot. MEDISAN [online]. 2018, vol.22, n.3, pp. 223-233. ISSN 1029-3019.

A descriptive and cross-sectional study of 56 patients with diabetes mellitus to whom diabetic foot was diagnosed, belonging to the health area of "Josué País García" University Polyclinic in Santiago de Cuba was carried out from January to December, 2016, in order to determine the cost-benefit of the treatment with Heberprot-P^®. This treatment was beneficial, because the cure of all patients was achieved. It is concluded that, in spite of the high cost that represents the administration of the novel treatment, it constituted a significant benefit for those affected, since the use of expensive surgical techniques and the amputations were avoided; also, it favored a better life quality, the socially useful life was expanded, the problems decreased from the social point of view as well as the high expenditure of expenses in social care

Palavras-chave : cost-benefit; diabetes mellitus; diabetic foot; Heberprot-P^®; primary health care.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )